The sleep disorder treatment developer has raised an additional $17.1m in a round led by medical device maker Cochlear.
Implantable hearing aid producer Cochlear has invested €13m to lead a €15m ($17.1m) funding round for Nyxoah, a Belgium-based company creating medical devices to treat sleeping disorders.
The other €2m was sourced from undisclosed existing Nyxoah shareholders and the round took the company’s total funding to more than $47m.
Nyxoah develops medical devices to treat patients suffering from obstructive sleep apnoea (OSA) who have failed conventional positive airway pressure therapy.
The company recently completed a clinical study examining nerve stimulation…
